U.S. federal trademark · Serial No. 98848247 · Reg. No. 2342244
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.